Methods of treating cancer using PD-L1 axis binding antagonists and VEGF antagonists
US9895441B2 · kind B2 · utility
2Cited by
8References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 1, 2014 |
| Grant date | Feb 20, 2018 |
| Priority date | — |
| Expiry date | Dec 1, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/507
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes combination treatment comprising a PD-1 axis binding antagonist, chemotherapy and optionally a VEGF antagonist and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired such as increasing tumor immunogenicity for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.